AR098287A2 - Métodos y composiciones para la detección de contaminantes microbianos en soluciones para diálisis peritoneal - Google Patents

Métodos y composiciones para la detección de contaminantes microbianos en soluciones para diálisis peritoneal

Info

Publication number
AR098287A2
AR098287A2 ARP140104124A ARP140104124A AR098287A2 AR 098287 A2 AR098287 A2 AR 098287A2 AR P140104124 A ARP140104124 A AR P140104124A AR P140104124 A ARP140104124 A AR P140104124A AR 098287 A2 AR098287 A2 AR 098287A2
Authority
AR
Argentina
Prior art keywords
peptidoglycan
reagent
peritoneal dialysis
solution
glucose polymer
Prior art date
Application number
ARP140104124A
Other languages
English (en)
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34887248&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR098287(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of AR098287A2 publication Critical patent/AR098287A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4722Proteoglycans, e.g. aggreccan
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • External Artificial Organs (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Reivindicación 1: Un método para fabricar una solución para diálisis peritoneal caracterizado porque comprende: proveer un polímero de glucosa; agregar un reactivo al polímero de glucosa, donde el reactivo es capaz de reaccionar con un peptidoglicano; determinar una proporción del peptidoglicano; utilizar el polímero de glucosa para preparar la solución para diálisis peritoneal si se determina que está presente un nivel suficientemente bajo del peptidoglicano. Reivindicación 4: El método de la reivindicación 1, caracterizado porque el reactivo deriva de un plasma de larvas de gusano de seda. Reivindicación 7: El método de la reivindicación 1, caracterizado porque la solución a base de un polímero de glucosa incluye una icodextrina. Reivindicación 17: El método de la reivindicación 16, en el cual se recoge un efluente de diálisis del paciente para determinar una respuesta de IL-6 que se correlaciona con una incidencia de peritonitis. Reivindicación 20: Un método para ensayar en una solución para diálisis peritoneal la presencia de un organismo gram positivo que exceda un nivel suficiente como para causar peritonitis, caracterizado porque comprende: agregar un reactivo a la solución para diálisis peritoneal, donde el reactivo es capaz de reaccionar con el peptidoglicano para iniciar una cascada de serina proteasa; y determinar la proporción del peptidoglicano. Reivindicación 27: Una composición de un polímero de glucosa caracterizada porque comprende un reactivo que es capaz de reaccionar con un peptidoglicano.
ARP140104124A 2004-02-27 2014-11-03 Métodos y composiciones para la detección de contaminantes microbianos en soluciones para diálisis peritoneal AR098287A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/789,320 US7118857B2 (en) 2004-02-27 2004-02-27 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions

Publications (1)

Publication Number Publication Date
AR098287A2 true AR098287A2 (es) 2016-05-26

Family

ID=34887248

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050100715A AR047900A1 (es) 2004-02-27 2005-02-25 Metodos y composiciones para la deteccion de contaminantes microbianos en soluciones para dialisis peritoneal
ARP140104124A AR098287A2 (es) 2004-02-27 2014-11-03 Métodos y composiciones para la detección de contaminantes microbianos en soluciones para diálisis peritoneal

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP050100715A AR047900A1 (es) 2004-02-27 2005-02-25 Metodos y composiciones para la deteccion de contaminantes microbianos en soluciones para dialisis peritoneal

Country Status (17)

Country Link
US (4) US7118857B2 (es)
EP (1) EP1720999B1 (es)
JP (2) JP5334412B2 (es)
KR (1) KR100940173B1 (es)
CN (2) CN1918302A (es)
AR (2) AR047900A1 (es)
AT (1) ATE421997T1 (es)
AU (1) AU2005226756B2 (es)
BR (1) BRPI0508219A (es)
CA (1) CA2555209A1 (es)
DE (1) DE602005012574D1 (es)
DK (1) DK1720999T3 (es)
ES (1) ES2321631T3 (es)
PL (1) PL1720999T3 (es)
SG (2) SG158178A1 (es)
TW (1) TWI344368B (es)
WO (1) WO2005093087A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8450079B2 (en) * 2003-10-31 2013-05-28 Immunetics, Inc. Method for detecting bacteria
US7118857B2 (en) 2004-02-27 2006-10-10 Baxter International Inc. Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
WO2009117558A2 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Destruction of microbial products by enzymatic digestion
US20090239819A1 (en) * 2008-03-20 2009-09-24 Run Wang Peritoneal dialysis solution test method
US20090239238A1 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Methods for measuring pro-inflammatory substance levels in dialysis solutions and dialysis components
US20090269733A1 (en) * 2008-04-23 2009-10-29 Azko, Inc. Devices and Methods for the Rapid Analysis of Pathogens in Biological Fluids
US9348975B2 (en) 2008-05-02 2016-05-24 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8377012B2 (en) 2009-01-30 2013-02-19 Baxter International Inc. Transfer sets for therapy optimization
US8282829B2 (en) 2009-05-20 2012-10-09 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US9020827B2 (en) * 2009-10-16 2015-04-28 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
FR2955861B1 (fr) 2010-02-02 2013-03-22 Roquette Freres Polymeres solubles de glucose branches pour la dialyse peritoneale
WO2012109473A2 (en) * 2011-02-09 2012-08-16 University Of Massachusetts Detection of endotoxins
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
CN103619372A (zh) 2011-03-23 2014-03-05 纳科斯达格医药股份有限公司 腹膜透析系统、装置和方法
EP2609918A1 (en) * 2011-12-27 2013-07-03 Zytoprotec GmbH Peritoneal dialysis fluid comprising a GSK-3 inhibitor
US8585635B2 (en) 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
WO2013178931A1 (fr) * 2012-05-29 2013-12-05 Roquette Freres Méthodes de décontamination des circuits de production de polymères de glucose et d'hydrolysats de polymères de glucose
EP2900802A4 (en) 2012-09-25 2016-05-25 Gen Electric DISPOSABLE CONTAINER FOR COLLECTING BIOCONTAMINATED SAMPLES AND DETECTION OF MICROBES IN THESE
US9227005B2 (en) * 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer
US9857355B2 (en) 2013-03-26 2018-01-02 Roquette Freres Biological assay of peptidoglycans
US9382591B2 (en) * 2013-06-06 2016-07-05 Pall Corporation Compositions for detecting Alicyclobacillus microorganisms
CN103467608B (zh) * 2013-09-27 2015-08-26 华仁药业股份有限公司 艾考糊精及其制备方法
RU2641960C2 (ru) * 2013-12-16 2018-01-23 Дмитрий Анатольевич Складнев Способ обнаружения микробной и вирусной контаминации растворов и биологических жидкостей
MX2016009774A (es) * 2014-02-07 2016-11-14 Roquette Freres Ensayo biologico de peptidoglicanos.
US20170281845A1 (en) * 2016-04-04 2017-10-05 Medtronic, Inc. Peritoneal dialysate fluid generation system
WO2018037360A1 (en) 2016-08-26 2018-03-01 Sequana Medical Ag Systems and methods for managing and analyzing data generated by an implantable device
GB201616718D0 (en) * 2016-09-30 2016-11-16 Microbiosensor Limited Microbial sensing devices
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
AU2018223035A1 (en) * 2017-10-03 2019-04-18 Medtronic, Inc. Peritoneal dialysate temperature regulation system
US11207454B2 (en) 2018-02-28 2021-12-28 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems
CN109400722A (zh) * 2018-11-13 2019-03-01 华仁药业股份有限公司 一种用于去除淀粉水解物中肽聚糖的方法
CN109264812A (zh) * 2018-11-13 2019-01-25 华仁药业股份有限公司 一种用于去除淀粉水解物中内毒素的方法
US11280788B2 (en) * 2019-01-31 2022-03-22 Fresenius Medical Care Holdings, Inc. Rapid diagnosis of peritonitis in peritoneal dialysis patients
WO2023170680A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761237A (en) 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
US4886789A (en) 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US6077836A (en) 1983-01-12 2000-06-20 Ml Laboratotries, Plc Peritoneal dialysis and compositions for use therein
US6248726B1 (en) 1985-06-22 2001-06-19 M L Laboratories Plc Method of peritoneal dialysis using glucose polymer solutions
ATE106410T1 (de) 1985-06-22 1994-06-15 Ml Lab Plc In kontinuierlicher peritonealdialyse verwendete polymere.
EP0634656B1 (en) 1986-12-03 2000-01-12 Wako Pure Chemical Industries, Ltd. Processes for collecting body fluid from insects
DE4242926C2 (de) * 1992-12-18 1994-12-15 Fresenius Ag Dialyselösung für die Peritonealdialyse
KR100299630B1 (ko) 1993-01-19 2001-11-22 데이비드 씨. 맥키, 토마스 제어. 시바티노 다중챔버용기
FR2716199B1 (fr) * 1994-02-15 1996-04-26 Roquette Freres Procédé de fabrication d'un hydrolysat d'amidon à faible indice de polymolécularité, nouvel hydrolysat d'amidon ainsi obtenu et son utilisation en dialyse péritonéale.
DE19748290B8 (de) * 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
US6770148B1 (en) 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
JP2002037705A (ja) * 2000-07-26 2002-02-06 National Agricultural Research Organization 耐酸耐熱性細菌用抗菌剤
US20040121982A1 (en) 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US7118857B2 (en) * 2004-02-27 2006-10-10 Baxter International Inc. Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions

Also Published As

Publication number Publication date
EP1720999A1 (en) 2006-11-15
AU2005226756B2 (en) 2008-08-28
ES2321631T3 (es) 2009-06-09
SG145769A1 (en) 2008-09-29
US20100056990A1 (en) 2010-03-04
CN1918302A (zh) 2007-02-21
EP1720999B1 (en) 2009-01-28
TW200538137A (en) 2005-12-01
DE602005012574D1 (de) 2009-03-19
CN101879181A (zh) 2010-11-10
KR20060126571A (ko) 2006-12-07
US20130338102A1 (en) 2013-12-19
JP2007525506A (ja) 2007-09-06
KR100940173B1 (ko) 2010-02-03
PL1720999T3 (pl) 2009-07-31
AR047900A1 (es) 2006-03-01
DK1720999T3 (da) 2009-05-04
JP5334412B2 (ja) 2013-11-06
TWI344368B (en) 2011-07-01
US7618392B2 (en) 2009-11-17
WO2005093087A1 (en) 2005-10-06
JP2011140519A (ja) 2011-07-21
CA2555209A1 (en) 2005-10-06
US20060263842A1 (en) 2006-11-23
US7118857B2 (en) 2006-10-10
SG158178A1 (en) 2010-01-29
US8859222B2 (en) 2014-10-14
US20050191717A1 (en) 2005-09-01
BRPI0508219A (pt) 2007-07-17
AU2005226756A1 (en) 2005-10-06
ATE421997T1 (de) 2009-02-15
US8546097B2 (en) 2013-10-01

Similar Documents

Publication Publication Date Title
AR098287A2 (es) Métodos y composiciones para la detección de contaminantes microbianos en soluciones para diálisis peritoneal
JP2007525506A5 (es)
AR059635A1 (es) Determinacion de analitos de temperatura para sistema biosensor
TW200641352A (en) Oxidizable species as an internal reference in control solutions for biosensors
BRPI0507322A (pt) biosensor eletroquìmico
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
JP5896764B2 (ja) 直接的凝固因子阻害剤を決定するためのへパリン非感受性方法
ATE520986T1 (de) Proteasenachweis
WO2010057184A3 (en) Methods for detection of acute kidney injury in humans
MX350533B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
WO2003084388A3 (en) Early detection of sepsis
EP2128612A3 (en) IP-10 based immunological monitoring
EP1611836A3 (en) Fluid handling methods
ATE414061T1 (de) Lumineszenter indikatorfarbstoff und optischer sensor
ATE544063T1 (de) Nanoporenvorrichtung und verfahren zur nukleinsäureanalyse
NZ590411A (en) Enhanced immunoassay sensor
SG169968A1 (en) Adhesive composition for use in an immunosensor
ATE514787T1 (de) Nachweis von proteasen
NZ624614A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ES2674177T3 (es) Preparación de suero
NZ606124A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2007047924A3 (en) Improved target ligand detection
UY29918A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
HK1123358A1 (en) Detection of circulating endothelial cells
ATE533053T1 (de) Nicht-elispot-test

Legal Events

Date Code Title Description
FC Refusal